Researchers assigned parents to give their children Ocean Spray Cranberry Classic cranberry juice or placebo daily for six months.
Another human clinical trial has linked cranberry consumption to reduced recurrence of urinary tract infections (UTIs). This time, it’s with children.
Previous clinical trials have linked cranberry juice consumption to fewer UTI recurrences in adults, but evidence of an effect in children is lacking. The double-blind, placebo controlled trial recruited 263 children suffering from recent UTIs.
Researchers assigned parents to give their children Ocean Spray Cranberry Classic cranberry juice (n=129) or placebo (n=134) daily for six months. Assessment of any recurring UTIs was conducted for one year and researchers observed a 43% reduction in the cranberry group compared to the placebo group.
Children in the cranberry group also decreased antibiotic use by 34% compared to placebo. That reduced use of antibiotics is likely to result in a body with less resistance to antibiotics in the future.
The results of this trial are available at the journal Clinical Infectious Diseases (link above).
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.